Attached files

file filename
10-K - FORM 10-K - Cannabics Pharmaceuticals Inc.cnbx_10k-083114.htm
EX-31.1 - Cannabics Pharmaceuticals Inc.cnbx_10k-ex3101.htm
EX-31.2 - CERTIFICATION - Cannabics Pharmaceuticals Inc.cnbx_10k-ex3102.htm
EX-32.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc.cnbx_10k-ex3201.htm
EXCEL - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.Financial_Report.xls

Exhibit 32.2

 

CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Annual Report of CANNABICS PHARMACEUTICALS INC. (the “Company”) on Form 10-K for the year ending August 31st, 2014, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Zohar Koren, Chief Financial Officer (Principal Financial Officer) of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. Such Annual Report on Form 10-K for the year ending August 31st, 2014 , fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in such Annual Report on Form 10-K for the year ending August 31st, 2014 , fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

       
Date: December 15, 2014 By: /s/ Zohar Koren  
    Zohar Koren  
   

Chief Financial Officer

(Principal Financial Officer)

CANNABICS PHARMACEUTICALS INC.